ISIN | LU2275403207 |
---|---|
Valor Number | |
Bloomberg Global ID | |
Fund Name | Bellevue Digital Health U2 USD |
Fund Provider |
Bellevue Asset Management AG
Zürich, Switzerland Phone: +41 44 267 67 00 E-Mail: info@bellevue.ch Web: www.bellevue.ch |
Fund Provider | Bellevue Asset Management AG |
Representative in Switzerland |
Waystone Fund Services (Switzerland) SA Lausanne Phone: 0041213111781 |
Distributor(s) | |
Asset Class | Equities |
EFC Category | |
Distribution Policy | Accumulation |
Home Country | Luxembourg |
Issuing Condition | Combination of issuing commission charged by the fund management company and transaction fee charged by the fund |
Redemption Condition | Combination of redemption commission charged by the fund management company and transaction fee charged by the fund |
Investment Strategy *** | The sub-fund is an equity fund. The investment objective of the sub-fund is to achieve long-term capital growth by investing at least two thirds of the net assets of the sub-fund in a portfolio of carefully chosen shares and other equity securities of companies whose business activities have a strong focus on the digitisation of the health sector or whose main activity involves holding investments in such companies or financing such companies and that have their registered office or carry out the majority of their economic activity in recognised countries. Without limiting the scope of the term Digital Health, businesses in the digital health sector comprise companies that are in a good position in the segments of diagnostics, healthcare IT, life sciences tools, medical technology, healthcare service providers or wellness to be able to benefit from the advent of digital technologies. |
Peculiarities |
Current Price * | 82.86 USD | 31.10.2024 |
---|---|---|
Previous Price * | 84.21 USD | 30.10.2024 |
52 Week High * | 87.01 USD | 19.09.2024 |
52 Week Low * | 60.83 USD | 10.11.2023 |
NAV * | 82.86 USD | 31.10.2024 |
Issue Price * | ||
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 331,003,444 | |
Unit/Share Assets *** | ||
Trading Information SIX |
YTD Performance | +5.01% |
29.12.2023 - 31.10.2024
29.12.2023 31.10.2024 |
---|---|---|
YTD Performance (in CHF) | +7.78% |
29.12.2023 - 31.10.2024
29.12.2023 31.10.2024 |
1 month | -3.29% |
30.09.2024 - 31.10.2024
30.09.2024 31.10.2024 |
3 months | +8.13% |
31.07.2024 - 31.10.2024
31.07.2024 31.10.2024 |
6 months | +10.23% |
30.04.2024 - 31.10.2024
30.04.2024 31.10.2024 |
1 year | +40.27% |
31.10.2023 - 31.10.2024
31.10.2023 31.10.2024 |
2 years | +5.27% |
31.10.2022 - 31.10.2024
31.10.2022 31.10.2024 |
3 years | -37.39% |
02.11.2021 - 31.10.2024
02.11.2021 31.10.2024 |
5 years | -36.26% |
15.06.2021 - 31.10.2024
15.06.2021 31.10.2024 |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
Intuitive Surgical Inc | 9.17% | |
---|---|---|
PROCEPT BioRobotics Corp | 8.71% | |
Insulet Corp | 8.24% | |
Exact Sciences Corp | 6.54% | |
Natera Inc | 4.95% | |
Veeva Systems Inc Class A | 4.75% | |
Globus Medical Inc Class A | 4.68% | |
Align Technology Inc | 4.59% | |
Ambu AS Class B | 4.43% | |
Penumbra Inc | 4.33% | |
Last data update | 30.09.2024 |
TER | 1.12% |
---|---|
TER date | 29.01.2021 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | |
Ongoing Charges *** | 1.01% |
SRRI ***
|
|
SRRI date *** | 30.09.2024 |
Low Carbon Designation *** | |
---|---|
ESG Rating Overall *** | |
ESG Rating Corporate *** | |
ESG Rating Sovereign *** | |
% AuM H&S Controversies *** |
Avg Carbon Risk Score *** | |
---|---|
Avg Carbon Risk Cat Avg *** | |
% AuM Covered Carbon *** | |
Avg Fossil Fuel Exposure *** | |
Fossil Fuel Cat Avg *** |
Strategy Level 1 *** | |
---|---|
Strategy Level 2 *** | |
Strategy Level 3 *** | |
Exclusions Level 1 *** | |
Exclusions Level 2 *** |